This paper re-examines the evidence linking poor growth during the era of import substituting industialization with trade restrictions.
This policy brief is a preview of the analysis and recommendations in Trade Policy and Global Poverty, by William R. Cline.
We use a public economics framework to consider how pharmaceuticals should be priced when at least some of the R&D incentive comes from sales revenues. We employ familiar techniques of public finance to relax some of the restrictions implied in the standard use of Ramsey pricing. We use this framework to examine on-going debates regarding the international patent system as embodied in the WTO's TRIPS agreement.
This brief assesses the impact of AGOA to date and recommends measures to improve its development potential.
At the United Nations Millennium Summit in 2000 the nations of the world committed to join forces to meet a set of measurable targets for reducing world poverty, disease, illiteracy and other indicators of human misery—all by the year 2015. These targets, later named the Millennium Development Goals, include seven measures of human development in poor countries. At the same summit, world leaders took on several qualitative targets applicable to rich countries, later collected in an eighth Goal. The key elements of the eighth Goal, pledge financial support and policy changes in trade, debt relief, and other areas to assist poor countries'domestic efforts to meet the first seven Goals. Combined, the eight Goals constitute a global compact between poor and rich to work today toward their mutual interests to secure a prosperous future.